Med LifeLTS:0RO5 75 EV-to-FCF is 996.71 as of Jul. 04, 2026, which is 2533% above its 10-year median of 37.85. GuruFocus rates LTS:0RO5 with a GF Score™ of 75/100 and a GF Value™ of lei1.39 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Med Life ranks worse than 98.03% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Med Life's Enterprise Value is lei8,772 Mil.
Med Life's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was lei9 Mil. Therefore, Med Life's EV-to-FCF for today is 996.71.
The historical rank and industry rank for Med Life's EV-to-FCF or its related term are showing as below:
LTS:0RO5'
s EV-to-FCF Range Over the Past 10 Years
Min: -850.88 Med: 37.85 Max: 906.24
Current: 906.24
During the past 11 years, the highest EV-to-FCF of Med Life was 906.24. The lowest was -850.88. And the median was 37.85.
LTS:0RO5's EV-to-FCF is ranked worse than 98.03% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.73
vs LTS:0RO5: 906.24
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-04), Med Life's stock price is lei11.3753.
Med Life's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was lei0.002. Therefore, Med Life's PE Ratio (TTM) for today is 5,687.65.
Med Life (LTS:0RO5) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Med Life's share price for today is lei11.3753.
Med Life's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Med Life EV-to-FCF Related Terms
Med Life EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Med Life's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Med Life's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Med Life's EV-to-FCF falls into.
Med Life's current Enterprise Value is lei8,772 Mil.
Med Life's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (LTS:0RO5) has a EV-to-FCF of 996.71 as of Jul. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Med Life and its competitors. This is 2533% above median its historical median of 37.85. According to the industry distribution chart, Med Life ranks #398 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 98%.
Is Med Life's EV-to-FCF too high?
Med Life's current EV-to-FCF of 996.71 is 2533% above median its 10-year median of 37.85. The Healthcare Providers & Services industry median EV-to-FCF is 17.73. Med Life's value of 996.71 is 5521.6% above this industry median. Based on the distribution chart, Med Life ranks #398 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Med Life has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #398 out of 406 companies for EV-to-FCF. This places Med Life in the lower half of its industry. The industry median EV-to-FCF is 17.73. Med Life's value of 996.71 is 5521.6% above this benchmark. While the company's 10-year median is 37.85 vs. the industry median of 17.73, Med Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.73, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current EV-to-FCF of 996.71 is 5521.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current EV-to-FCF is 996.71, which is 2533% above median its own 10-year median of 37.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.39, compared to a current price of lei11.38 — trading 718.4% above its estimated fair value. The current EV-to-FCF is 996.71, which is 2533% above median its 10-year median of 37.85 and 5521.6% above the Healthcare Providers & Services industry median of 17.73. Med Life's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current EV-to-FCF is 996.71 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (LTS:0RO5) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.38 is trading 718.4% above its estimated GF Value™ of lei1.39.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for LTS:0RO5:
EV-to-FCF: 996.71 (2533% above median its 10-year median of 37.85)
GF Value™: lei1.39 vs. price of lei11.38 (718.4% above fair value)
Industry Position: 5521.6% above the Healthcare Providers & Services median (#398 of 406)
No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
75GF Score
Get the complete analysis for LTS:0RO5
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RO5 has been successfully added to your 
